← FDA Drug Approvals (Drugs@FDA)

JUBBONTI

BLA · Biologics License Application · Sponsor: SANDOZ INC · Approved 2024-03-05

Drug application

FDA Application #
BLA761362
Application type
Biologics License Application
Brand name
JUBBONTI
Generic name
DENOSUMAB
Active ingredients
DENOSUMAB-BBDZ
Dosage form
INJECTABLE
Route
SUBCUTANEOUS
Marketing status
Prescription
Sponsor
SANDOZ INC
Manufacturer
Sandoz Inc
First approval
2024-03-05

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown